We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Is White Blood Cell Variation Diagnostic for Some Cancers?

By LabMedica International staff writers
Posted on 23 Oct 2012
Print article
The potential use of white blood cell variation as a diagnostic, predictive, and research tool in the study of non-blood cancers is being studied.

Dr. Devin Koestler, a biostatistician at the Geisel School of Medicine at Dartmouth (Hanover, NH, USA) and colleagues are studying the potential of white cell variation for diagnostic purposes. Dr. Koestler develops and applies statistical methods to large volumes of data, seeking new approaches for understanding disease, cancer in particular. He is focused on the development and application of statistical methods for analyzing genomic data.

Working in the Quantitative Biomedical Sciences Program, Dr. Koestler's focus is the development of computational and statistical tools for investigating the process of DNA methylation. In methylation, a methyl group attaches itself to the DNA sometimes causing the DNA function to change dramatically. For example, the methyl group might block the expression of a tumor-suppressing gene.

“When we have an illness or a disease, that does something to our immune system,” Dr. Koestler explains. “It responds by providing whatever cells are necessary to combat that threat. In the blood, the leukocytes supply that immune response.”

The studies showed differences in methylation patterns in the leukocytes of cancer patients versus cancer-free individuals. Each type of leukocytes, or subset, exhibits its own distinctive signature methylation pattern. The proportions of these identifiable subsets shift, depending on the kind of disease they may be combating.

Using data from studies of ovarian, bladder, and head and neck cancers, the scientists demonstrated statistically significant correlations between the specific cancers and the methylation signatures that characterize leukocyte subsets. Analyzing the relative proportions of the leukocyte types in the blood sample can help predict the onset of a particular cancer or identify and diagnose a cancer in progress. The alternative of sampling a patient’s blood is far preferable to undergoing an invasive surgical biopsy.

The advantages of using methylation patterns to assess proportions of white blood cell subtypes in cancer studies extend beyond the bedside to the lab bench. Dr. Koestler said, “There is promise here for a new diagnostic tool. What we show here is not ready for immediate clinical utility, but I think it is on the right path.”

Related Links:

Geisel School of Medicine at Dartmouth


New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
Tabletop Centrifuge
Mikro 185

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.